(E)-2-Hexenal Combats Rice Sheath Blight Through Direct Pathogen Inhibition and Host Defense Reprogramming
Plants · 21.05.2026 · 15 (10) · 1581
DOI: 10.3390/plants15101581 ↗Kurz gefasst
Fachartikel in der Zeitschrift Plants, online erschienen am 21.05.2026. Verfasst von Wenyan Fan und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Plant Protection, Yangzhou University, Yangzhou 225009, China. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Volatile organic compounds (VOCs) have garnered substantial research interest in recent years due to their biodegradability, low toxicity, and potent antimicrobial properties against various plant pathogens. As a typical herbivore-induced plant volatile (HIPV) elicited by Nilaparvata lugens (Brown planthopper, BPH), (E)-2-hexenal has been identified as a promising natural antimicrobial agent. In this study, we investigated the protective potential of (E)-2-hexenal against Rhizoctonia solani (R. solani) in rice, focusing on both its direct antifungal activity and host-mediated defense mechanisms. In vitro antifungal assays demonstrated that treatment with 100 μL/mL (E)-2-hexenal resulted in a 91.07% inhibition of R. solani mycelial growth after 48 h. Scanning electron microscopy (SEM) observation and chitinase activity analysis revealed that (E)-2-hexenal suppressed fungal growth by disrupting the structural integrity of the pathogen cell wall. Furthermore, 100 μL/mL (E)-2-hexenal effectively conferred protection to detached rice leaves. Whole-plant inoculation assays confirmed that (E)-2-hexenal pretreatment significantly alleviated disease symptoms and triggered systemic resistance in rice plants. Physiological and biochemical analyses showed that (E)-2-hexenal treatment enhanced the activities of defense-related enzymes, elevated hydrogen peroxide (H2O2) levels, and promoted the accumulation of defensive metabolites in rice leaves. HPLC-MS quantification further revealed significant increases in the endogenous levels of jasmonic acid (JA) and salicylic acid (SA). Transcriptomic KEGG pathway enrichment analysis indicated that differentially expressed genes (DEGs) were mainly involved in alpha-linolenic acid metabolism, diterpenoid biosynthesis, phenylpropanoid biosynthesis, plant–pathogen interaction, and plant hormone signal transduction. Collectively, these results suggest that (E)-2-hexenal enhances rice resistance to sheath blight disease via a dual-action mechanism: direct inhibition of fungal development and activation of host immune responses. Our findings highlight the potential application of (E)-2-hexenal and other VOCs in developing eco-friendly strategies for sustainable rice disease management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Plant Protection, Yangzhou University, Yangzhou 225009, China.
- Jiangsu Province Engineering Research Center of Green Pesticides, Yangzhou University, Yangzhou 225009, China.
ORCID-Profile: Xinyan Liang, Yiping Wang, Jinglan Liu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Fan, W., Wang, W., Liang, X., Feng, L., Lv, X., Li, J., Wang, Y., & Liu, J. (2026). (E)-2-Hexenal Combats Rice Sheath Blight Through Direct Pathogen Inhibition and Host Defense Reprogramming. Plants, 15(10), 1581. https://doi.org/10.3390/plants15101581
Vancouver
Fan W, Wang W, Liang X, Feng L, Lv X, Li J, et al. (E)-2-Hexenal Combats Rice Sheath Blight Through Direct Pathogen Inhibition and Host Defense Reprogramming. Plants. 2026;15(10):1581. doi:10.3390/plants15101581
BibTeX
@article{Fan2026,
author = {Fan, Wenyan and Wang, Wenjuan and Liang, Xinyan and Feng, Liting and Lv, Xinyi and Li, Jitong and Wang, Yiping and Liu, Jinglan},
title = {(E)-2-Hexenal Combats Rice Sheath Blight Through Direct Pathogen Inhibition and Host Defense Reprogramming},
journal = {Plants},
year = {2026},
volume = {15},
number = {10},
pages = {1581},
doi = {10.3390/plants15101581}
}
EUVIMED